Stryker (SYK) vs. Its Competitors Head to Head Analysis

Stryker (NYSE:SYK) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its rivals? We will compare Stryker to similar businesses based on the strength of its analyst recommendations, earnings, profitability, valuation, risk, dividends and institutional ownership.

Dividends

Stryker pays an annual dividend of $3.52 per share and has a dividend yield of 1.1%. Stryker pays out 37.5% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.1% and pay out 47.8% of their earnings in the form of a dividend. Stryker has increased its dividend for 32 consecutive years.

Risk and Volatility

Stryker has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, Stryker’s rivals have a beta of 2.57, suggesting that their average stock price is 157% more volatile than the S&P 500.

Valuation and Earnings

This table compares Stryker and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Stryker	$25.12 billion	$3.25 billion	33.76
Stryker Competitors	$1.90 billion	$135.83 million	5.88

Stryker has higher revenue and earnings than its rivals. Stryker is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings and target prices for Stryker and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0	7	21	0	2.75
Stryker Competitors	4291	10579	18364	831	2.46

Stryker presently has a consensus price target of $342.19, indicating a potential upside of 7.96%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.18%. Given Stryker’s rivals higher possible upside, analysts plainly believe Stryker has less favorable growth aspects than its rivals.

Profitability

This table compares Stryker and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Stryker	13.78%	23.74%	11.64%
Stryker Competitors	-304.20%	-315.07%	-22.11%

Institutional and Insider Ownership

77.1% of Stryker shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 4.6% of Stryker shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Stryker beats its rivals on 10 of the 15 factors compared.

Stryker Company Profile

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.